VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 25, 2011) - Centurion Minerals Ltd. (TSX VENTURE:CTN) ("Centurion", "the Company") is pleased to announce that it has engaged Maison Placements Canada Inc. to act as the lead agent in a private placement of 5,000,000 Units priced at $0.40 for total gross proceeds of $2,000,000. Each Unit will consist of one common share and one half warrant. Each whole warrant will be exercisable for one common share at $0.55 for a period of eighteen months following the closing. The agent shall have the option to increase the size of the issue by up to 15%.

Proceeds from this financing will be used for accelerating the exploration program on the Company's Banda Raya project wherein significant gold assays from samples were recently reported, and for general working capital purposes. The offering is subject to the approval of the TSX Venture Exchange.


Centurion Minerals Limited is an Indonesian-based, Canadian-headquartered company focused on the exploration and development of gold, copper and other precious metal projects in Indonesia.

On Behalf of the Board,

David G. Tafel, President and CEO

This news release may contain forward looking statements concerning future operations of Centurion Minerals Ltd. (the "Company"). All forward looking statements concerning the Company's future plans and operations, including management's assessment of the Company's project expectations or beliefs may be subject to certain assumptions, risks and uncertainties beyond the Company's control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and exploration and financial results may differ materially from any estimates or projections.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

Centurion Minerals Ltd.
Investor Relations
(604) 484-2161
Toll Free (North America): 1-877-784-2161